Anika Therapeutics Inc (ANIK) is a publicly traded Healthcare sector company. As of November 6, 2026, ANIK trades at $19.50 with a market cap of $273.01M and a P/E ratio of -70.81. ANIK moved +0.88% today. Year to date, ANIK is +103.85%; over the trailing twelve months it is +95.99%. Its 52-week range spans $7.87 to $22.88. Analyst consensus is buy with an average price target of $23.00. Rallies surfaces ANIK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover ANIK: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $23.00.
| Metric | Value |
|---|---|
| Price | $19.50 |
| Market Cap | $273.01M |
| P/E Ratio | -70.81 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.88 |
| 52-Week Low | $7.87 |
| Volume | 210 |
| Avg Volume | 0 |
| Revenue (TTM) | $120.65M |
| Net Income | $-3.78M |
| Gross Margin | 62.16% |
2 analysts cover ANIK: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $23.00.